TEV ‘325, which targets IL-13 and TSLP, is being studied for the treatment of TH2-driven inflammatory diseases such as asthma ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its first ...

As the biopharma industry moves into the new year, Teva is looking to put the past behind it. After proposing a blockbuster $4.25 billion opioid settlement, the drugmaker has secured participation ...

TEL AVIV, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2026 Aide Memoire is available on the “Investors” page on its ...

Teva®, a division of Deckers Brands (NYSE: DECK), introduces its Spring 2026 collection, the next evolution of its For ...

Is TEVA a good stock to buy? We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra ...

We believe that Teva Pharmaceutical stock (NYSE: TEVA) is a good buying opportunity at the present time. TEVA stock trades near $10 currently and it is, in fact, down 28% from its pre-Covid high of ...

The share price of Israeli chipmaker Tower Semiconductor Ltd. (Nasdaq: TSEM; TASE:TSEM) rose 31.2% on Nasdaq last week, ...

As a closely watched “skinny” labeling legal imbroglio rolls on, branded drugmaker GlaxoSmithKline has notched another win against Israeli-American generics juggernaut Teva Pharmaceutical. Industry ...

Teva Pharmaceutical active in generic medicines sector Strong quarterly performance reported exceeding estimates Significant ...